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Background: The current pilot study compares the impact of an intravenous infusion of Ringer’s lactate to an
acetate-based solution with regard to acid–base balance. The study design included the variables of the Stewart
approach and focused on the effective strong ion difference. Because adverse hemodynamic effects have been
reported when using acetate buffered solutions in hemodialysis, hemodynamics were also evaluated.
Methods: Twenty-four women who had undergone abdominal gynecologic surgery and who had received either
Ringer’s lactate (Strong Ion Difference 28 mmol/L; n = 12) or an acetate-based solution (Strong Ion Difference 36.8
mmol/L; n = 12) according to an established clinical protocol and its precursor were included in the investigation.
After induction of general anesthesia, a set of acid–base variables, hemodynamic values and serum electrolytes was
measured three times during the next 120 minutes.
Results: Patients received a mean dose of 4,054 ± 450 ml of either one or the other of the solutions. In terms of
mean arterial blood pressure and norepinephrine requirements there were no differences to observe between the
study groups. pH and serum HCO3
- concentration decreased slightly but significantly only with Ringer’s lactate. In
addition, the acetate-based solution kept the plasma effective strong ion difference more stable than Ringer’s
lactate.
Conclusions: Both of the solutions provided hemodynamic stability. Concerning consistency of acid base
parameters none of the solutions seemed to be inferior, either. Whether the slight advantages observed for the
acetate-buffered solution in terms of stability of pH and plasma HCO3
- are clinically relevant, needs to be
investigated in a larger randomized controlled trial.
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In the fields of surgery and intensive care, hyperchlore-
mic acidosis is a well-known problem in patients receiv-
ing large amounts of standard crystalloids, especially
0.9% sodium chloride solutions. A series of investiga-
tions has emphasized the disadvantageous effects of
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distribution, and reproduction in any mediumexample, hemodynamics, NO-production, renal blood
circulation, urinary output or hemostasis [1-4]. Balanced
crystalloids, whose composition prevents hyperchlore-
mia, are increasingly accepted and likely to be ‘state
of the art’ in the near future [3,5-7]. Balanced
hydroxyethyl-starch solutions are also available today.
All of these preparations are characterized by the pres-
ence of metabolizable organic anions such as lactate,
acetate or malate and contain physiological electrolyte
concentrations. Theoretically, balanced solutions which
possess a strong ion difference (SID) of around 24Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.










Strong ion difference 28 36.8
mosmol/L
Osmolarity (calculated) 276 291
Osmolality (in vivo) 256 270
[], serum concentration of the ion between the brackets; ABIS, acetate-based
infusion solution.
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tate) are supposed to have no influence on blood pH
even after intravenous infusion of several liters [8]. How-
ever, balanced crystalloids containing lactate have some
disadvantages as well [9]. Their metabolism depends on
liver function and does require increased oxygen con-
sumption. Acetated solutions do not display these
shortcomings, but previous studies in patients under-
going hemodialysis have demonstrated that their ad-
ministration may lead to hemodynamic instability and
hypotension [10].
Despite their future perspective, to date the routine
use of balanced crystalloids is still infrequent in
anesthesia. Large randomized, controlled clinical trials
(RCT’s) investigating possible advantages as well as ad-
verse effects of balanced crystalloids for routine use in
the operating theater are sparse. The aim of the current
study was to provide a preliminary comparison of two
differently buffered balanced infusion solutions by
reviewing data obtained from two established clinical
protocols and,in addition, to test the feasibility of a
future large RCT. The main target of interest was to
investigate the influence of a solution containing a
plasma-like SID (acetate buffered, SID= 36.8 mmol/L)
and a solution with a comparably low SID (lactate buf-
fered, SID= 28 mmol/L) on the variables of Stewart’s
acid–base approach including the effective strong ion
difference (SIDe). The impact of the acetate-based infu-
sion solution on hemodynamic stability was also studied.
In order to guide a future RCT, primary and secondary
variables of interest were determined and sample size es-
timation was performed.Methods
In 2009 Ringer’s lactate (B. Braun Melsungen, Melsun-
gen, Germany) was replaced by IonosterilTM (Fresenius
Medical Care, Schweinfurt, Germany), an acetate-based
infusion solution (ABIS), as a standard intraoperative
infusion solution in our institution. In a before and
after analysis we studied acid–base balance and hemo-
dynamics in 24 women without obvious cardiac, pul-
monary or renal diseases (classified as American Society
of Anesthesiologists physical status I or II) who under-
went major, open gynecologic cancer surgery. The study
comprised two arms: the first consisted of patients who
had received solely Ringer’s lactate (RL-group, n = 12)
and the second of women who were treated only with
the ABIS (ABIS-group, n = 12). The composition of both
infusion solutions is listed in Table 1. Patients suffering
from pre-existing acid–base disorders and patients
who required blood transfusions, plasma products or
colloids during the study period were not included
in the investigation. A retrospective chart review wasperformed for patients in both arms. The mean inter-
group difference of changes in SIDe between baseline
values and the end of the study period was defined as
the primary variable of interest. Changes in arterial
plasma pH and noradrenalin requirements during gen-
eral anesthesia were considered as secondary variables.
The target parameters of the study were obtained from
intraoperative routine blood samples, taken from arterial
lines in patients requiring postoperative intensive care
management (see Table 2). Because no additional blood
sampling was necessary and the study was designed
to evaluate two different versions of an established infu-
sion regimen, the Ethics Committee of the University of
Munich waived the need for patient’s informed consent
for this pilot trial.
General anesthesia was induced with intravenous pro-
pofol, sufentanil, and cis-atracurium. After tracheal in-
tubation, anesthesia was maintained with propofol (6 to
10 mg/kg/hour) and additional doses of sufentanil and
cis-atracurium as appropriate. Mechanical ventilation
was performed to maintain an adequate oxygenation and
to preserve normocapnia. Intraoperative monitoring
included end-tidal PaCO2, electrocardiography, central
venous pressure, arterial blood pressure, pulseoximetry
and esophageal temperature. During the operative
period, the patient’s temperature was kept constant in
any case. Urinary output as well as the blood loss during
the time course of the investigation was noted. In order
to obtain blood pH, base excess (BE), HCO3
- and PaCO2,
a standard blood gas analyzer (Bayer Rapidlab 1265,
Bayer Healthcare LLC, East Walpole, MA, USA) was
used. Serum electrolyte and lactate concentrations, as
well as hemoglobin, hematocrit and albumin concentra-
tions were assessed in the central laboratory of our
Table 2 List of variables
Measurement at: Measurement at:
Hemodynamics Acid Base Balance
Noradrenalin requirement (mg/h) BL – T120 Anion Gap (mmol/L) BL – T120
Heart rate (min-1) BL – T120 HCO3- (mmol/L) BL – T120
ABP systolic (mmHg) BL – T120 BE (mmol/L) BL – T120
ABP diastolic (mmHg) BL – T120 pH BL – T120
Central venous pressure (mmHg) BL – T120 paCO2 (mmHg) BL – T120
Blood loss (mL) BL – T120
Hemoglobin (g/dL) BL – T120 Stewart Acid Base Approach [A-] (mmol/L) BL – T120
Hematocrit (%) BL – T120 Effective Strong Ion Difference (mmol/L) BL – T120
Urine quantity (mL) BL – T120 Strong Ion Gap (mmol/L) BL – T120
Administered amount of RL/ABIS (mL) BL – T120 [Albumin] (g/L) BL – T120
[Serum-Lactate] (mmol/L) BL – T120
Serum-Electrolytes([Na+][Cl-] [K+] [Mg++] [Ca++]) BL – T120 [A-]: = Serum-concentration of week acids BL – T120
ABIS, acetate-based infusion solution; ABP, arterial blood pressure; BE, base excess; BL, baseline; [], serum concentration of the variable between the brackets.
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measurements the following variables were calculated:
 [PO43-] ionized (Pi) (mmol/L): = [PO43-] (mg/dL) 
0.3229
 Anion gap (mmol/L): = [Na+] – [Cl-] – [HCO3-]
 Effective Strong Ion Difference (SIDe) (mmol/L): =
[A-] + [HCO3
-] = [A-] + (0.0304  PCO2  10(pH-6.1))
according to Figge [11,12]
 Week acids serum-concentration [A-] (mmol/L): =
[Albumin  (0.123  pH – 0.631)] + [Pi  (0.309  pH -
0.469)] according to Figge [11,12]
 Strong Ion Gap (SIG) (mmol/L): = [Na+] + [K+] + 2
[Ca++] + 2[Mg++] – [Cl-]–[Lac-]–[A-]–[HCO3
-]
according to Stewart [13]
Hemodynamics
In accordance with our institution’s clinical practice a
mean arterial pressure (MAP) of at least 80 mmHg was
regarded as necessary during general anesthesia. If vol-
ume replacement with the study solutions alone (up to
30 ml/kg/hour) was not sufficient to maintain the neces-
sary level of MAP norepinephrine was administered in
increasing doses of 0.1 mg/hour as required until the
target value was achieved.
Statistical analysis
Mean, standard deviation of the mean (parametric
values), median and range (non-parametric data) were
calculated for each target parameter. The Shapiro-Wilk
test was used to test for normality. Because most of the
data were normally distributed, they are presented as
mean ± standard deviation. We used a repeated measure-
ment analysis of variances (RM-ANOVA) followed by a
Student-Newman-Keuls test (with data normallydistributed) or a Friedman test (with data not normally
distributed) to describe changes of measurement para-
meters within a group during the course of time (three
points of measurement). In order to compare differences
between the groups an ANOVA was followed by a
Student-Newmann-Keuls test (see above). If data were
not normally distributed a one-way ANOVA on ranks
(Kruskal-Wallis test) was followed by Dunn’s test. For all
determinations a type I error protection of P<0.05 was
considered significant. Statistical analysis was performed
using Sigma Stat Software Version 3.1 (RockWare Inc.
Golden, Colorado, USA) and Microsoft Excel Version
2003 (Microsoft Deutschland GmbH, Unterschleißheim,
Germany). All electrolyte concentrations are expressed
as mmolLl.Results
We did not notice significant differences concerning
patients’ demographic data (mean age: RL-group, 64 ± 8;
ABIS-group, 61 ± 10 years; mean body mass index: RL-
group, 24.8 ± 2.6; ABIS-group, 24.5 ± 3.5; mean body
weight: RL-group, 68.6 ± 6.0 kg; ABIS-group, 66.4 ± 14.0
kg) (P> 0.05 for all comparisons). All women underwent
surgery for ovarian cancer including open radical hyster-
ectomy, adnexal surgery and para-aortal as well as pelvic
lymph node dissection. Twenty-four patients, who a
priori fulfilled the inclusion criteria, were enrolled in this
study (12 per group). Protocol violations were not
observed and subsequently there was no need to retro-
spectively exclude patients from the trial. The mean
intergroup difference of changes in SIDe between BL
and T120 proved to be 2.08 ± 2.9 mmol/L, indicating a
strong effect (d = 0.91) according to Cohen [14]. Thus,
assuming an effect size of 2 mmol/L, a future RCT
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given a type II error protection of β> 0.8.
Acid–base balance and Stewart approach
Parameters contributing to the ‘classic’ acid–base balance
(see Table 3) did not differ significantly between groups at
any time point of measurement. Intergroup comparisons
concerning parameters relevant for Stewart’s acid–base
approach, especially the SIDe, showed no significant dif-
ferences, either. However, values noticed for the RL-group
showed small but significant intragroup changes during
the time course, especially concerning pH and [HCO3
-]. In
the ABIS-group, these values did not change. In addition,
relevant intragroup reductions were observed in SIDe and
[A-] for RL and ABIS. Albumin serum concentrations
were diminished to approximately 80% of their basic
values in both groups.
Hemodynamics
The overall mean blood loss during the time course was
763 ± 427 ml; it was 655 ± 460 ml in the RL-group and
870 ± 378 ml in the ABIS-group (P> 0.05). The total
amount of the infused study solutions was 4,066 ± 308
ml for RL and 4,041 ± 572 ml for the ABIS (P> 0.05).
Norepinephrine requirements increased constantly dur-
ing the study period, but differences between groups did
not reach significance. Nevertheless, a slight but signifi-
cant reduction in CVP could be observed in the RL-Table 3 Acid–base parameters
BL
Mean± SD 95% CI Mean± S
[HCO3
- ] RL* 24.65 ± 2.69 (22.94-26.36) 23.86 ± 2.
ABIS 25.09 ± 2.52 (23.49-26.69) 25.19 ± 1.
BE RL* 0.38 ± 2.89 (−1.46-2.22) −1.11 ± 3.
ABIS 0.48 ± 2.63 (−1.19-2.15) 0.45 ± 1.
pH RL* 7.42 ± 0.05 (7.39-7.45) 7.39 ± 0.
ABIS 7.41 ± 0.03 (7.39-7.43) 7.42 ± 0.
paCO2 (mmHg) RL 39.56 ± 1.5 (38.61-40.51) 39.58 ± 1.
ABIS 40.35 ± 2.77 (38.59-42.11) 40.55 ± 2.
[A-] RL* 12.51 ± 1.2 (11.75-13.27) 10.52 ± 1.
ABIS* 12.80 ± 2.35 (11.31-14.29) 10.12 ± 1.
SIDe RL* 37.90 ± 3.75 (35.52-40.28) 34.34 ± 3.
ABIS* 37.45 ± 3.00 (35.54-39.36) 35.34 ± 2.
SIG RL* 4.95 ± 3.38 (2.80-7.10) 1.67 ± 3.
ABIS° 2.98 ± 2.31 (1.51-4.45) 1.56 ± 1.
Albumin[g/l] RL* 37.0 ± 4.31 (34.26-39.74) 30.58 ± 3.
ABIS* 35.82 ± 7.70 (30.93-40.71) 29.18 ± 4.
All values except paCO2, albumin and pH are given in mmol/L. ABIS, acetate-based
lactate; SD, standard deviation; SIDe, effective strong ion difference; SIG, strong ion
confidence interval of means; І Δ120 І, absolute value of the difference between T1
(P< 0.05) between BL and T120; °, Significant intragroup changes over time (P< 0.0group. There were no differences in urine output. Fur-
ther parameters listed under ‘Hemodynamics’ in Table 4
were not significantly different between groups.
Electrolytes
Serum electrolytes were measured mainly to calculate
the parameters of the Stewart approach. Except for [lac-
tate-] and [Mg++] no significant differences between the
study groups were observed (see Table 5). Significantly
higher levels of [Mg++] could be found in the ABIS-
group at T60 and T120. Serum lactate concentrations
were significantly elevated for RL compared to ABIS at
T60 and T120 (P< 0.05 for all comparisons). In
addition, a significant increase in [Cl-] could be noticed
during the time course in the RL-group (Table 5), but
not in the ABIS-group.
Discussion
The current investigation was designed to compare two
currently available balanced infusion solutions in a clin-
ical setting. One solution contained lactate, the other
acetate as a metabolizable anion. Main areas of interest
were the influence of these solutions on acid–base bal-
ance and hemodynamic stability.
Acid–base balance
On first sight, the acid–base parameters pH, BE and
[HCO3
-] remained remarkably constant during the timeT60 T120 ІΔ120І
D 95% CI Mean± SD 95% CI Mean± SD
86 (22.04-25.68) 23.41 ± 3.62 (21.11-25.71) 1.24 ± 1.72
85 (24.01-26.37) 24.53 ± 2.31 (23.06-26.00) 0.56 ± 1.79
3 (−3.21-0.99) −1.63 ± 3.63 (−3.94-0.68) 2.0 ± 1.87
99 (−0.81-1.71) −0.07 ± 2.51 (−1.66-1.52) 0.54 ± 1.46
04 (7.36-7.42) 7.37 ± 0.03 (7.35-7.39) 0.05 ± 0.02
04 (7.39-7.45) 7.39 ± 0.04 (7.36-7.42) 0.03 ± 0.03
46 (38.65-40.51) 40.73 ± 3.04 (38.80-42.66) 1.16 ± 2.69
85 (38.74-42.36) 40.95 ± 1.87 (39.76-42.14) 0.6 ± 2.40
05 (9.85-11.19) 9.81 ± 2.0 (8.54-11.08) 2.69 ± 1.70
39 (9.24-11.00) 10.12 ± 1.82 (8.96-11.28) 2.67 ± 2.40
19 (32.31-36.37) 33.20 ± 4.81 (30.16-36.28) 4.71 ± 2.71
50 (33.75-36.93) 34.82 ± 4.00 (32.28-37.36) 2.63 ± 1.75
03 (−0.26-3.60) 0.73 ± 4.43 (−2.08-3.54) 4.21 ± 2.93
0 (0.92-2.20) 2.44 ± 1.99 (1.18-3.70) 0.54 ± 2.76
68 (28.24-32.92) 28.41 ± 6.91 (24.02-32.80) 8.60 ± 5.71
21 (26.51-31.85) 29.10 ± 5.58 (25.55-32.65) 6.72 ± 8.45
infusion solution; BE, base excess; BL, baseline measurement; RL, Ringer’s
gap; T60, T120, measurement at 60 ± 10 and 120 ± 10 minutes; 95% CI, 95%
20 and baseline measurements. *, Significant intragroup changes over time
5) between BL and T60.
Table 4 Hemodynamics
BL T60 T120 ІΔ120І
Mean± SD 95% CI Mean± SD 95% CI Mean± SD 95% CI Mean± SD
Norepinephrine requirements (mg/hour) RL* 0.1 ± 0.1 (0.04-0.16) 0.3 ± 0.2 (0.17-0.43) 0.4 ± 0.3 (0.21-0.59) 0.3 ± 0.3
ABIS* 0.1 ± 0.1 (0.04-0.16) 0.3 ± 0.2 (0.17-0.43) 0.5 ± 0.4 (0.25-0.75) 0.41 ± 0.4
Urine-Quantity (ml) RL* 8.3 ± 19.4 (−4.03-20.63) 210.8 ± 165.2 (105.84-315.76) 630.8 ± 422.2 (362.5-899.0) 622.5 ± 404.4
ABIS* 15.8 ± 31.7 (−4.34-35.94) 216.6 ± 153.3 (119.20-314.00) 533.3 ± 286.2 (351.4-715.1) 517.5 ± 271.6
HR (min-1) RL 55.2 ± 10.9 (48.27-62.13) 56.1 ± 11.8 (48.60-63.60) 58.7 ± 13.6 (50.06-67.34) 3.5 ± 5.3
ABIS 55.0 ± 6.3 (51.00-59.00) 60.8 ± 10.4 (54.19-67.41) 59.9 ± 13.9 (51.07-68.73) 4.9 ± 10.0
MAP mmHg) RL 86.4 ± 8.9 (80.75-92.05) 85.5 ± 11.7 (78.07-92.93) 84.4 ± 11.5 (77.09-91.71) 2.0 ± 11.2
ABIS 88.9 ± 13.3 (80.45-97.35) 94.1 ± 15.7 (84.12-104.08) 91.3 ± 15.0 (81.77-100.83) 2.4 ± 14.8
CVP (mmHg) RL* 11.2 ± 2.3 (9.74-12.66) 10.7 ± 3.5 (8.48-12.92) 8.8 ± 3.5 (6.58-11.02) 2.4 ± 3.4
ABIS 10.9 ± 3.2 (8.87-12.93) 12.7 ± 5.3 (9.33-16.07) 11.4 ± 4.4 (8.60-14.20) 0.57 ± 5.4
ABIS, acetate-based infusion solution; BL, baseline measurement; CVP, central venous pressure; HR, heart rate; MAP, mean arterial pressure; RL, Ringer’s lactate; SD,
standard deviation; T60, T120, measurement at 60 ± 10 and 120 ± 10 minutes; 95% CI, 95% confidence interval of means; І Δ120 І, absolute value of the difference
between T120 and baseline measurements; *, significant intragroup changes over time (P< 0.05) between BL and T120.
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previous investigators [4,8]. However, it was evident that
the ABIS had less influence on the ‘classic’ acid–base
parameters than RL. pH, [HCO3
-] and BE did not change
from BL to T120 in the ABIS-group, whereas a small
but significant reduction of pH values and [HCO3
-] could
be observed in the RL-group. Concerning the para-
meters of Stewart’s acid–base model, we noticed a
relevant reduction in serum albumin concentrations,
which is easily explained by the diluting effects of the
albumin-free crystalloid solutions. This reduction wasTable 5 Serum electrolyte concentrations
BL
Mean± SD 95% CI Mean± SD
[Na+] RL* 137.3 ± 4.8 (134.2-140.4) 136.2 ± 4.7
ABIS 138.9 ± 2.5 (137.3-140.5) 138.3 ± 2.3
[K+] RL* 3.5 ± 0.2 (3.4-3.7) 3.6 ± 0.3
ABIS* 3.5 ± 0.3 (3.31-3.70) 3.7 ± 0.3
[Cl-] RL* 101.8 ± 5.4 (99.0-104.8) 105.8 ± 5.0
ABIS 105.5 ± 3.3 (103.4-107.6) 108.4 ± 2.5
[Mg2+] RL* 0.77 ± 0.1 (0.71-0.82) 0.69 ± 0.1#
ABIS 0.83 ± 0.06 (0.79-0.87) 0.85 ± 0.04#
[Ca2+] RL 1.16 ± 0.04 (1.13-1.19) 1.16 ± 0.04
ABIS 1.17 ± 0.03 (1.15-1.19) 1.16 ± 0.03
[Lac-] RL* 0.8 ± 0.3 (0.66-1.07) 1.6 ± 0.6#
ABIS 0.9 ± 0.4 (0.64-1.15) 0.8 ± 0.3#
[PO4
3-] RL 3.5 ± 0.4 (3.21-3.78) 3.4 ± 0.4
(mg/dL) ABIS 3.4 ± 0.5 (3.08-3.719 3.3 ± 0.5
All values except [PO4
3-] are given in mmol/L. ABIS, acetate-based infusion solution;
T120, measurement at 60 ± 10 and 120 ± 10 minutes; 95% CI, 95% confidence interv
baseline measurements; *, significant intragroup changes over time (P <0.05) betw
time points of measurement (P< 0.05).accompanied by a corresponding decrease in [A-] (Δ BL-
T120: RL-group, 2.70 mmol/L; ABIS-group, 2.68 mmol/L).
In addition, the SIDe declined as well. In contrast to [A
-] a
small difference in the quantity of the decline could be
observed with SIDe (Δ BL-T120: RL-group, 4.7 mmol/l;
ABIS-group, 2.6 mmol/L; P> 0.05). Although the differ-
ence in SIDe-reduction was not significant between
groups, one can speculate that the pronounced decrease
of effective SID in the RL-group (which should lead to
an acidosis according to the Stewart approach) was only
incompletely neutralized by the decrease in [A-] (whichT60 T120 ІΔ120І
95% CI Mean± SD 95% CI Mean± SD
(133.2-139.2) 135.8 ± 5.1 (132.5-139.0) 1.52 ± 1.65
(136.8-139.7) 138.5 ± 2.7 (136.8-140.2) 0.35 ± 2.9
(3.40-3.79) 3.7 ± 0.5 (3.38-4.01) 0.26 ± 0.52
(3.50-3.89) 3.7 ± 0.2 (3.57-3.82) 0.22 ± 0.31
(102.6-109.0) 107.5 ± 4.6 (104.6-110.4) 5.60 ± 2.4
(106.8-110.0) 108.6 ± 2.2 (107.2-110.0) 3.08 ± 1.46
(0.62-0.75) 0.66 ± 0.1# (0.59-0.72) 0.11 ± 0.12
(0.82-0.87) 0.87 ± 0.04# (0.84-0.89) 0.04 ± 0.06
(1.13-1.18) 1.16 ± 0.02 (1.14-1.17) 0.00 ± 0.03
(1.14-1.18) 1.16 ± 0.03 (1.14-1.17) 0.01 ± 0.02
(1.21-1.98) 1.9 ± 0.7# (1.45-2.34) 0.94 ± 0.69
(0.60-1.0) 0.8 ± 0.2# (0.67-0.92) 0.12 ± 0.22
(3.14-3.65) 3.3 ± 0.4 (3.04-3.55) 0.19 ± 0.32
(3.00-3.60) 3.4 ± 0.6 (3.02-3.78) 0.01 ± 0.28
BL, baseline measurement; RL, Ringer’s lactate; SD, standard deviation; T60,
al of means; І Δ120 І, absolute value of the difference between T120 and
























Figure 1 Reduction of [A-], SIDe and [HCO3
- ] during the time course (BL – T120). ABIS, acetate-based infusion solution; BL, baseline; RL,
Ringer’s lactate; T120, measurement at 120 ±minutes; SIDe, effective strong ion difference; *, significant intragroup changes over time (P <0.05)
between BL and T120..
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but significant pH reduction that could be observed in
the RL-group (see Figure 1).
This finding is surprising, because it does not corres-
pond to Morgan’s theory of the ‘ideal SID’ [7]. According
to Morgan et al. only infusion solutions with a SID of
around 24 mmol/L do not influence blood pH. As a con-
sequence one should have expected RL (SID 28 mmol/
L) rather than ABIS (SID 36.8 mmol/L) to guarantee pH
stability and ABIS to cause a mild alkalosis. Neverthe-
less, in the current study ABIS, whose SID nearly
approximates normal plasma SIDe (39 ± 4 mmol/L), pro-
vided better pH stability [15]. We have no explanation
for the discrepancy concerning Morgan’s theory. One
can only speculate that perhaps infusion rate and/or
metabolic turnover of the metabolizable anions may be
important in this situation. In addition, according to
Wooten’s multi-compartmental model, not only extra-
cellular, but also intracellular effects, and fluid redistri-
bution between compartments may have influenced
acid–base chemistry [16].
One possible limitation of the current study was that
some of the values (especially the SID) had to be calcu-
lated from directly measured parameters. With differ-
ences between and within groups being very small, a
propagation of errors could have influenced group com-
parisons. However, modern blood gas analyzers, as used
in the current study, are able to measure acid–base vari-
ables extremely precisely (pH bias <0.005, PaCO2 bias
< 1.2 mmHg) [17]. In addition, measurement errors
concerning the components of SID should occur simi-
larly in all patients. Therefore, differences between
groups should not be affected.
In summary, there were no significant intergroup dif-
ferences to observe. Compared to RL, ABIS showed lessinfluence on the ‘classic’ acid–base parameters (pH, BE,
[HCO3
-]) and the solution did not provoke a clinically
relevant change in plasma SIDe. These results are in ac-
cordance with a recently published investigation on
trauma patients requiring intensive care treatment with
regard to pH stability provided by acetated solutions
[18]. The clinical relevance of the relatively small
intragroup changes in this study may be a matter of dis-
cussion. Scientific research on hyperchloremic acidosis
has revealed that even small changes in pH can have a
negative impact on various organ systems [1,2,4,19]. In
addition, fluid requirements during major surgery may
exceed by far the amount of four liters of crystalloids
administered during the current study. Thus, small (but
significant) differences concerning acid–base stability of
applied crystalloids may gain importance successively if
increasing amounts of fluids are administered.
Hemodynamic values
Hemodialysis with acetate-containing solutions can be
the cause of severe hemodynamic instability because of
increased nitric oxide synthesis and enhanced arrhyth-
mias [20-22]. Even the small quantity of acetate present
in various dialysis fluids (usually 35 mmol/L) exposes a
patient's blood to an acetate concentration 10 to 40
times the physiological level (50 to 100 μmol/L) [23-25].
Fournier et al. observed that, according to the nature of
hemodialysis (counter current process), the concentra-
tion of plasma acetate increased from 0.02 mmol/L to
0.22 mmol/L in three hours of hemodialysis [25]. To
date, it is unknown whether the administration of ace-
tated infusion solutions can provoke substantial rises in
plasma acetate levels as well. However, one can speculate
that while (slowly) infusing acetate-containing solu-
tions, a considerably greater amount of the substance
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should lead to relatively low serum concentrations.
This assumption is supported by two different observa-
tions: Firstly, no significant differences could be observed
in terms of hemodynamic values between the study
groups. Secondly, the SIG in the ABIS-group did not
change significantly during the time course. According to
Stewart’s approach, an increase in plasma acetate must
lead to an increase in SIG [13]. This hypothesis has been
confirmed by Bruegger et al. in a hemorrhagic shock ca-
nine model: A 2.2 mmol/L rise in acetate plasma levels
caused an identical (absolute) increase in SIG [26]. As a
consequence, it is unlikely that relevant amounts of acet-
ate accumulated in the circulation in the ABIS-group.
However, hemodynamic stability could only be maintained
by administering increasing amounts of norepinephrine
(P < 0.05 from BL to T120 in both of the groups). There
are several possible explanations: Firstly, the range
of blood loss was relatively broad (from 50 ml up to
1,500 ml). Despite fluid replacement, which, according to
the literature, should have been adequate, these fluid
losses were obviously not sufficiently counterbalanced in
some of the patients, especially in the ABIS-group [27,28].
It seems probable that some patients developed a mild
hypovolemia during the time course of the study. This as-
sumption is supported by a decreasing CVP in the ABIS
group, in which blood loss tended to be more severe than
in the RL-group. Secondly, one has to take into account
the mild vasodilatory effect of the used narcotics (propofol)
that may have contributed to norepinephrine require-
ments. Thus, when considering only the current, preli-
minary data it seems that both solutions ‘behaved like
normal crystalloids’ without substance-specific hemody-
namic effects. However, it will be interesting to investigate
if small intergroup differences observed for CVP or MAP
which, nevertheless, are of clinical importance, will gain
significance in a larger RCT.
Additional findings
Slightly elevated lactate levels were observed in the RL-
group. These increases were only moderate (but sig-
nificant) and hardly exceeded our institutions’ range of
normal values (0.5 to 1.5 mmol/L). In contrast to ABIS
[Mg++] significantly decreased in the RL-group. Because
RL does not contain magnesium, this can best be
explained by a simple dilution effect. We consider these
changes to be of minor clinical importance. However,
for patients suffering from liver or metabolic diseases or
cardiac arrhythmias ABIS might be the preferable infu-
sion solution.
Feasibility of a future RCT
The current study showed that a larger RCT is feasible.
The preliminary sample size estimation did not includethe possibility of protocol violations or dropouts. There-
fore, at least 35 patients will have to be enrolled in each
group. With regard to the consistency of the study
population in terms of co-factors of surgery and demo-
graphic data it is likely that a large RCT will provide reli-
able and reproducible results, despite the small
intergroup differences in primary and secondary values
of interest we observed.Conclusions
In the current preliminary comparison Ringer’s lactate
as well as ABIS proved to be suitable for fluid replace-
ment during abdominal surgery. Hemodynamic stability
remained unaffected by both of the solutions. Concern-
ing consistency of acid base parameters none of the
solutions seemed to be clearly inferior, either. ABIS had
a smaller effect on pH, BE, [HCO3-] and SIDe changes
than lactated Ringer, but whether these differences will
turn out to be of clinical relevance has to be investigated
in a larger RCT. With regard to SIDe and [A-] neither
ABIS nor Ringer’s lactate seem to be ‘ideally balanced’,
because both of these values decreased dose dependently
in both groups. A future RCT might provide important
data concerning the on-going search for an ideal
balanced solution.
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